Shine Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 5.00 Cr
as on 23-10-2024
- Paid Up Capital ₹ 3.38 Cr
as on 23-10-2024
- Company Age 30 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 0.68 M
as on 23-10-2024
- Satisfied Charges ₹ 9.30 Cr
as on 23-10-2024
- Revenue 18.64%
(FY 2023)
- Profit -27.72%
(FY 2023)
- Ebitda -25.92%
(FY 2023)
- Net Worth 17.78%
(FY 2023)
- Total Assets 11.07%
(FY 2023)
About Shine Pharmaceuticals
The Corporate was formerly known as Shine Pharmaceuticals Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 Cr and a paid-up capital of Rs 3.38 Cr.
The company currently has active open charges totaling ₹0.68 M. The company has closed loans amounting to ₹9.30 Cr, as per Ministry of Corporate Affairs (MCA) records.
Pradeep Agrawal, Hiranmay Saha, Aloka Saha, and Three other members serve as directors at the Company.
- CIN/LLPIN
U24231GJ1994PLC022787
- Company No.
022787
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
17 Aug 1994
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Vadodara, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Shine Pharmaceuticals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Samir Chakraborty  | Managing Director | 01-Apr-2005 | Current |
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Pradeep Agrawal | Whole-Time Director | 01-Jul-2003 | Current |
| Hiranmay Saha | Director | 30-May-1996 | Current |
| Aloka Saha | Whole-Time Director | 30-May-1996 | Current |
| Rangoli Gada | Director | 25-Mar-2023 | Current |
| Tejal Parikh | Director | 01-May-2024 | Current |
Financial Performance and Corporate Structure Insights of Shine Pharmaceuticals.
Shine Pharmaceuticals Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 18.64% increase. The company also saw a substantial fall in profitability, with a 27.72% decrease in profit. The company's net worth Soared by an impressive increase of 17.78%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Shine Pharmaceuticals?
In 2023, Shine Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Interpharm Biotech Private LimitedActive 25 years 2 monthsPradeep Agrawal and Samir Chakraborty are mutual person
Bhoomi Medicaments LimitedActive 28 years 11 monthsPradeep Agrawal and Samir Chakraborty are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Axis Bank Limited Creation Date: 29 Jun 2019 | ₹0.68 M | Open |
Others Creation Date: 24 Dec 2020 | ₹2.00 Cr | Satisfied |
Others Creation Date: 26 Sep 2019 | ₹7.50 M | Satisfied |
How Many Employees Work at Shine Pharmaceuticals?
Shine Pharmaceuticals has a workforce of 721 employees as of Mar 28, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Shine Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Shine Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
